Europe authorizes emergency use of Merck's anti-Corona pills
The European Medicines Agency announced Friday that it has approved the emergency use in the European Union of pills developed by the Merck group to combat Covid, knowing that it has not yet obtained full marketing authorization for the tablets.
"This drug, which is not currently authorized in the European Union, can be used to treat adults with Covid-19 who do not need oxygen and are considered to be at higher risk of severe infection" of the disease, the agency said in a statement.
The United Kingdom was the first country in the world to approve the anti-Covid-19 drug “molnopiravir” from Merck Laboratories, which is considered an essential tool in the fight against the pandemic, at the beginning of this month.
Follow our latest local and sports news and the latest political and economic developments via Google news
:
#Corona,
#covid-19,
#merck_pills